The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Publication date
2013
Authors
Mou, H
Stalin Raj, V.
van Kuppeveld, Frank
Rottier, Peter
Haagmans, B.L.
Bosch, Berend Jan
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
The spike (S) protein of the recently emerged human Middle East respiratory syndrome coronavirus (MERS-CoV) mediates infection by binding to the cellular receptor dipeptidyl peptidase 4 (DPP4). Here we mapped the receptor binding domain in the S protein to a 231-amino-acid fragment (residues 358 to 588) by evaluating the interaction of spike truncation variants with receptor- expressing cells and soluble DPP4. Antibodies to this domain—much less so those to the preceding N-terminal region—efficiently neutralize MERS-CoV infection.
Keywords
Antibodies, Neutralizing, Antibodies, Viral, Binding Sites, Cell Line, Coronavirus, Dipeptidyl Peptidase 4, Epitopes, B-Lymphocyte, Humans, Membrane Glycoproteins, Receptors, Virus, Spike Glycoprotein, Coronavirus, Viral Envelope Proteins, Virus Attachment, Coronacrisis-Taverne
Citation
Mou, H, Stalin Raj, V, van Kuppeveld, F J M, Rottier, P J M, Haagmans, B L & Bosch, B J 2013, 'The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies', Journal of Virology, vol. 87, no. 16, pp. 9379-9383. https://doi.org/10.1128/JVI.01277-13